Position in ZTS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,344,597
-$4,522,797 QoQ
Shares Held
116,123
+6.7% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#269
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
|
61,364 | $974,459 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,344,597 | 116,123 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $12,867,394 | 108,852 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $10,083,717 | 80,144 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $18,845,136 | 128,794 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $22,194,958 | 142,321 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $19,770,183 | 120,074 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $20,977,725 | 128,753 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $31,615,218 | 161,814 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $29,332,857 | 169,202 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $28,197,999 | 166,645 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $34,125,863 | 172,903 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $37,095,318 | 213,216 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,832,062 | 161,617 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $28,614,030 | 171,918 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $26,125,759 | 178,272 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $24,541,400 | 165,496 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $28,342,596 | 164,888 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $38,574,384 | 204,541 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $46,709,293 | 191,408 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,651,346 | 204,241 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $40,603,556 | 217,877 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,832,684 | 221,188 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $34,360,446 | 207,616 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $32,684,055 | 197,642 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $26,550,401 | 193,742 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $20,589,982 | 174,951 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||